Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Cell Counting Kit-8 (CCK-8): Precision Assays for Biocompati
2026-06-03
Explore how the Cell Counting Kit-8 (CCK-8) enables advanced cell proliferation and cytotoxicity analysis, with a focus on assessing biocompatibility in cutting-edge materials. This article offers a deeper perspective on utilizing CCK-8 for evaluating novel biomedical coatings, setting it apart from standard protocol guides.
-
Homologous Recombination Defects and Olaparib Response in MP
2026-06-03
Borchert et al. (2019) reveal that homologous recombination repair (HRR) pathway defects, particularly those classified as 'BRCAness', are prevalent in malignant pleural mesothelioma (MPM) and correlate with increased sensitivity to PARP inhibition using olaparib in vitro. Their gene expression profiling identifies prognostic markers and suggests that stratification by HRR gene status could guide novel therapeutic strategies in MPM.
-
DRP1-Mediated Mitochondrial Fission Drives Glycolysis in ATI
2026-06-02
Sun et al. (2024) establish that hyperoxia activates DRP1-mediated mitochondrial fission, triggering glycolytic reprogramming in alveolar type II (ATII) cells—a mechanism relevant to bronchopulmonary dysplasia (BPD) pathogenesis. Their integrated workflow combines in vivo and in vitro models, advanced metabolic assays, and immunofluorescence to clarify the linkage between mitochondrial dynamics and metabolic dysregulation.
-
Cytarabine (AraC) Workflows: Optimizing Leukemia and Apoptos
2026-06-02
Cytarabine (AraC) from APExBIO empowers researchers to precisely interrogate DNA damage and apoptosis pathways, overcoming resistance mechanisms in leukemia models. This article delivers advanced workflows, troubleshooting strategies, and applied insights to maximize reproducibility and data quality in cell and animal studies.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Localization
2026-06-01
ARCA Cy5 EGFP mRNA (5-moUTP) redefines fluorescent mRNA tracking in mammalian cells with dual-labeling, advanced capping, and immune-evading modifications. This tool empowers researchers to achieve robust, quantitative mRNA delivery and in situ translation analyses, streamlining both troubleshooting and high-content assay development.
-
KN-62: Applied Calcium Signaling and Cell Cycle Arrest Workf
2026-06-01
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, empowers precise inhibition of CaMKII for dissecting calcium signaling, insulin secretion, and cell cycle regulation. This article delivers actionable protocols, troubleshooting strategies, and application insights to maximize reproducibility and selectivity in complex cellular models.
-
Native PAGE for Acidic Proteins: Powering Translational Insi
2026-05-31
This article explores the strategic and mechanistic power of native protein gel electrophoresis—focusing on acidic proteins (pI ≤ 7.0)—for translational research. We examine how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit enables structure-preserving discovery, cite recent breakthroughs in synthetic lethality for clear cell renal cell carcinoma, and offer actionable protocol guidance for researchers aiming to accelerate protein-driven therapeutic innovation.
-
C8-HSL Drives Lung Cancer Progression via PI3K/AKT/ERK Pathw
2026-05-30
This study uncovers that the quorum-sensing molecule N-octanoyl-L-Homoserine lactone (C8-HSL), produced by Gram-negative bacteria, promotes proliferation, migration, and invasion of lung cancer cells by activating the PI3K/AKT/ERK signaling cascade. The findings suggest that bacterial quorum-sensing signals may represent novel risk factors and potential therapeutic targets in lung cancer.
-
CLCC1 Identified as Host Factor for Herpesvirus Nuclear Egre
2026-05-29
A recent study uncovers CLCC1 as a critical host protein enabling herpesvirus nuclear egress via membrane fusion, resolving a longstanding mechanistic question in herpesvirus biology. These findings open new research avenues into host-virus interactions and inform future antiviral strategies targeting nuclear egress.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Illuminating Macrophage Gene D
2026-05-29
Explore how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, advances the direct visualization and mechanistic understanding of mRNA delivery in challenging cell types like macrophages. This article uniquely bridges assay design with recent innovation in targeted gene therapy.
-
Proteolytic Neuroligin 1 Fragments Sustain Social Memory in
2026-05-28
Liu et al. reveal that social interaction triggers specific proteolytic processing of neuroligin 1 in the ventral hippocampus, generating fragments essential for the maintenance of social memory. This study connects extracellular cues to synaptic remodeling, offering a mechanistic link between social experience and memory persistence.
-
Amikacin (BAY416651): Applied Protocols in Resistance Resear
2026-05-28
Amikacin (BAY416651) stands out as a robust and enzyme-resistant bacterial protein synthesis inhibitor, enabling reproducible workflows for dissecting resistance in multidrug-resistant Enterobacter cloacae and Klebsiella pneumoniae. Discover experimental best practices and advanced troubleshooting strategies that maximize the impact of this APExBIO research-grade aminoglycoside antibiotic.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guide
2026-05-27
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive and specific detection of rabbit IgG in immunofluorescence, IHC, and ICC workflows. It is best suited for applications requiring robust signal amplification and minimal background. This product is not intended for diagnostic or clinical use, and its utility is limited to research workflows using rabbit primary antibodies.
-
Latrunculin A: Strategic Insights for Translational Cytoskel
2026-05-27
Explore the mechanistic underpinnings and translational potential of Latrunculin A as a reversible inhibitor of actin assembly. This thought-leadership article navigates from the molecular rationale to protocol optimization and cross-domain virology applications, anchored by the latest proteomic evidence and practical guidance for advanced cytoskeleton research.
-
Docetaxel in Cancer Research: Protocols, Use-Cases & Trouble
2026-05-26
Docetaxel (Taxotere) is the cornerstone for dissecting microtubule dynamics and apoptosis in cancer models, offering unmatched precision for cell cycle and chemoresistance studies. This guide delivers actionable workflows, practical troubleshooting, and key insights from recent advances, ensuring researchers can fully leverage APExBIO’s Docetaxel for robust, reproducible oncology research.